Table 1 Distribution of baseline characteristics across categories of fish consumption: the Tromsø Study
From: Fish consumption, fish oil supplements and risk of atherosclerosis in the Tromsø study
Fish servings, times per week | |||||
|---|---|---|---|---|---|
Baseline characteristics | < 1 n = 258 | 1–1.9 n = 1325 | 2–2.9 n = 977 | ≥ 3 n = 1340 | p-trend |
Age, y | 58.4 (0.4) | 59.3 (0.2) | 61.8 (0.2) | 63.0 (0.2) | < 0.0001 |
Male, % | 40.8 | 46.6 | 54.1 | 55.0 | < 0.0001 |
Higher education, %a | 16.9 | 20.3 | 17.6 | 18.9 | 0.8 |
Physical active, % | 19.8 | 23.0 | 24.5 | 23.4 | 0.4 |
BMI, kg/m2 | 26.4 (0.2) | 25.9 (0.1) | 25.9 (0.1) | 26.1 (0.1) | 0.9 |
Total cholesterol, mmol/L | 6.83 (0.08) | 6.77 (0.03) | 6.79 (0.04) | 6.78 (0.03) | 0.9 |
LDL cholesterol, mmol/L | 4.48 (0.07) | 4.44 (0.03) | 4.46 (0.04) | 4.48 (0.03) | 0.7 |
HDL cholesterol, mmol/L | 1.50 (0.03) | 1.56 (0.01) | 1.57 (0.01) | 1.57 (0.01) | 0.07 |
LDL/HDL ratio | 3.20 (0.07) | 3.12 (0.03) | 3.05 (0.04) | 3.10 (0.03) | 0.3 |
Triglycerides, mmol/L | 1.85 (0.06) | 1.68 (0.03) | 1.66 (0.03) | 1.61 (0.03) | 0.002 |
Systolic blood pressure, mmHg | 146.7 (1.3) | 144.4 (0.6) | 146.2 (0.7) | 145.5 (0.6) | 0.6 |
Diastolic blood pressure, mmHg | 85.2 (0.8) | 83.4 (0.3) | 84.4 (0.4) | 83.9 (0.3) | 0.9 |
Hypertension, % | 60.2 | 53.9 | 56.9 | 56.4 | 0.7 |
Current smoking, % | 29.3 | 31.1 | 31.2 | 33.7 | 0.09 |
Diabetes, % | 2.5 | 2.8 | 1.7 | 2.8 | 0.9 |
Fish oil supplements, %b | 45.6 | 50.5 | 45.1 | 52.4 | 0.2 |
Antihypertensive medication, % | 11.7 | 10.3 | 10.7 | 9.8 | 0.4 |
Lipid-lowering medication, %c | 0.8 | 1.7 | 1.1 | 1.9 | 0.4 |
Leukocyte count, × 109/L | 6.76 (0.12) | 6.84 (0.05) | 6.95 (0.06) | 6.95 (0.05) | 0.048 |
Monocyte count, × 109/L | 0.59 (0.01) | 0.58 (0.01) | 0.59 (0.01) | 0.59 (0.01) | 0.2 |
Fibrinogen, g/L | 3.39 (0.05) | 3.38 (0.02) | 3.37 (0.03) | 3.40 (0.02) | 0.7 |
LogCRP, mg/ml | 0.31 (0.07) | 0.26 (0.03) | 0.22 (0.04) | 0.26 (0.03) | 0.6 |